Barclays analyst Kannan Venkateshwar lowered the firm’s price target on Altice USA (ATUS) to $2 from $3 and keeps an Equal Weight rating on the shares. The firm says the company’s balance sheet constraints are forcing “sub optimal go-to-market choices,” which will continue to pressure EBITDA.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATUS:
